NCT00096980View on ClinicalTrials.gov

A Study to Evaluate Raptiva in Combination With Topical Psoriasis Therapies

PHASE4CompletedINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

February 28, 2001

Study Completion Date

May 31, 2004

Conditions

Psoriasis

Interventions

DRUG

Raptiva (efalizumab)

Sponsors

Lead Sponsor

Genentech, Inc.

All Listed Sponsors

lead

Genentech, Inc.

INDUSTRY